Document:

Exhibit 10.5

 

SECURITIES
SUBSCRIPTION AGREEMENT

 

This
Securities Subscription Agreement (“Agreement”) is made and entered into as of May 25, 2022, by and between Translational
Development Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Stone Capital Partners LLC,
a Delaware limited liability company (the “Purchaser”).

 

WHEREAS,
the Purchaser desires to purchase and Company desires to issue and sell to the Purchaser Class B ordinary shares, par value of $US0.0001
each (the “Class B Shares”) on the terms and conditions set forth below.

 

NOW,
THEREFORE, in consideration of the premises and the mutual promises herein made, and in consideration of the representations, warranties,
and covenants herein contained, the parties intending to be legally bound, hereby agree as follows:

 

1.
The Transaction. Subject to the terms and conditions set forth in this Agreement, on a closing date to be agreed between the parties
hereto, Purchaser will purchase from the Company, and the Company will issue and sell to the Purchaser, 4,312,500 Class B Shares
(the “Purchased Shares”) for an aggregate purchase price of $25,000. An aggregate of up to 562,500 shares are subject
to forfeiture by the Purchaser depending on the extent to which the underwriters’ over-allotment option is not exercised.

 

2.
Representations and Warranties of the Company.

 

The
Company hereby represents and warrants to the Purchaser as follows:

 

2.1.
The Company (i) is an exempted company duly incorporated, validly existing and in good standing under the laws of the Cayman Islands,
and has full power and authority to own, lease and operate its properties and assets and to conduct its business as now being conducted;
and (ii) has all requisite legal and corporate power to execute and deliver this Agreement, and to carry out and perform its obligations
hereunder. All corporate actions on the part of the Company, its directors and shareholders, necessary for the authorization, execution,
delivery and performance of this Agreement and the performance of the Company’s obligations hereunder, have been taken. The execution
and the delivery of this Agreement and the consummation of the transactions contemplated hereby, will not violate any applicable law
or conflict with, or result in a breach of any agreement or other arrangement to which the Company is a party or by which it is bound.

 

2.2.
This Agreement constitutes the valid and binding obligation of the Company, legally enforceable against the Company in accordance with
its terms, except as such enforceability may be limited by (i) bankruptcy, insolvency, reorganization, moratorium and other similar
laws relating to or affecting creditors generally, or by general equity principles, and (ii) laws relating to the availability of
specific performance, injunctive relief, or other equitable remedies.

 

2.3.
The authorized share capital of the Company consists of 100,000,000 Class A ordinary shares of par value of US$0.0001 each, 10,000,000
Class B ordinary shares of par value of US$0.0001 each and 1,000,000 undesignated preferred shares of par value US$0.0001 each.

 

3.
Representations and Warranties of the Purchaser.

 

The
Purchaser hereby represents and warrants to the Company as follows:

 

3.1.
It has all requisite legal and corporate power to execute and deliver this Agreement, and to carry out and perform its obligations hereunder.
All corporate actions on the part of the Purchaser, its managers and partners, necessary for the authorization, execution, delivery and
performance of this Agreement and the performance of the Purchaser’s obligations hereunder, have been taken. The execution and
the delivery of this Agreement and the consummation of the transactions contemplated hereby, will not violate any applicable law or conflict
with, or result in a breach of any agreement or other arrangement to which the Purchaser is a party or by which it is bound.

 

    1 

     

    

 

3.2.
This Agreement constitutes a valid and legally binding obligation of the Purchaser, except (i) as limited by applicable bankruptcy,
insolvency, reorganization, moratorium, and other laws of general application affecting enforcement of creditors’ rights generally,
and (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.

   

3.3.
The Purchaser acknowledges that the Purchased Shares it is purchasing subject to the terms of this Agreement are characterized as “restricted
securities” under the federal securities laws in as much as they are being acquired from the Company in a transaction not involving
a public offering and that under such laws and applicable regulations such securities may be resold without registration under the U.S.
Securities Act of 1933, as amended (the “Act”), only in certain limited circumstances. In this connection, the Investor
represents that it is familiar with SEC Rule 144, as presently in effect, and understands the resale limitations imposed thereby
and by the Act.

 

3.4.
It is understood that certificates evidencing the Purchased Shares (if any) may bear one or all of the following legends or similar legend:

 

“THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED
OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER SUCH ACT OR AN OPINION OF COUNSEL
SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144 OF SUCH ACT.”

 

4.
Miscellaneous.

 

4.1.
Governing Law. This Agreement and the rights and obligations of the parties hereunder shall be construed in accordance with and
governed by the laws of New York applicable to contracts wholly performed within the borders of such state, without giving effect to
the conflict of law principles thereof.

 

4.2.
Entire Agreement. This Agreement constitutes the full and entire understanding and agreement between the parties hereto with regard
to the subjects hereof, and supersedes any and all prior agreements and understandings of the parties concerning such subject matter.
Neither this Agreement nor any term hereof may be amended, waived, discharged, or terminated other than by a written instrument signed
by both parties hereto.

 

4.3.
Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be enforceable against the party
actually executing such counterpart, and all of which together shall constitute one and the same instrument.

 

4.4.
Notices, Etc. All notices and other communications required or permitted hereunder shall be in writing and shall be deemed effectively
given on the earliest of the following: (a) the date of personal delivery; (b) one (1) business day after transmission
by facsimile, addressed to the other party at its facsimile number, with confirmation of transmission; (c) five (5) business
day after deposit with a return receipt express courier; or (d) seven (7) business days after deposit in local mail by registered
or certified mail. All notices not delivered personally or by facsimile will be sent with postage and/or other charges prepaid and properly
addressed at the address as either party shall have notified its counterpart.

 

[Signature
Page Follows]

 

    2 

     

    

  

IN
WITNESS WHEREOF, the parties have executed this Share Purchase Agreement as of the date first above written.

 

	TRANSLATIONAL
DEVELOPMENT ACQUISITION CORP.	 	STONE
CAPITAL PARTNERS LLC
	 	 	 
	By:	/s/
Michael B. Hoffman	 	By:	/s/
Michael B. Hoffman
	 	Michael
B. Hoffman, CEO	 	 	Michael
B. Hoffman, Managing Member

 

[Signature Page – Securities Subscription Agreement]Exhibit 10.6

PRIVATE WARRANTS PURCHASE AGREEMENT

 

THIS PRIVATE WARRANTS PURCHASE AGREEMENT, dated
as of [●], 2022 (as it may from time to time be amended, this “Agreement”), is entered into
by and between Translational Development Acquisition Corp., a Cayman Islands exempted company (the “Company”),
and Stone Capital Partners LLC (the “Purchaser”). 

 

RECITALS

 

WHEREAS, the Company intends to consummate an
initial public offering (the “Public Offering”) of the Company’s units (the “Units”),
each Unit consisting of one Class A ordinary share of the Company, par value $0.0001 per share (each, an “Ordinary Share”),
and one-half of one warrant (a “Warrant”) (each whole Warrant entitles the holder to purchase one Ordinary Share
at a price of $11.50 per share); and

 

WHEREAS, the Purchaser has agreed to purchase
an aggregate of 3,000,000 (or up to an aggregate of [              ], if the underwriters’ over-allotment option in connection with the Public
Offering is exercised in full) private placement warrants (the “Private Placement Warrants”).

 

NOW THEREFORE, in consideration of the mutual
promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section 1. Authorization, Purchase and Sale; Terms of the Private
Placement Warrants.

 

(a) Authorization of the Private Placement Warrants. The Company has
duly authorized the issuance and sale of the Private Placement Warrants to the Purchaser.

 

(b) Purchase and Sale of the Private Placement Warrants.

 

(i) On the date of the consummation of the Public
Offering or on such earlier time and date as may be mutually agreed by the Purchaser and the Company (the “Initial Closing
Date”), the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, 3,000,000
Private Placement Warrants at a price of $1.00 per Sponsor Warrant for an aggregate purchase price of $3,000,000 (the “Purchase
Price”), which shall be paid by wire transfer of immediately available funds to the Company at least one day prior to the
Initial Closing Date in accordance with the Company’s wiring instructions. On the Initial Closing Date, following the payment by
the Purchaser of the Purchase Price by wire transfer of immediately available funds to the Company, the Company, at its option, shall
deliver a certificate evidencing the Private Placement Warrants purchased on such date, duly registered in the Purchaser’s name
to the Purchaser, or effect such delivery in book-entry form.

 

(ii) On the date of any consummation of the closing
of the over-allotment option in connection with the Public Offering or on such earlier time and date as may be mutually agreed by the
Purchaser and the Company (each such date, an “Over-allotment Closing Date,” and each Over-allotment Closing
Date (if any) and the Initial Closing Date being sometimes referred to herein as a “Closing Date”), the Company
shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, up to an aggregate of [          ] Private Placement
Warrants, in the same proportion as the amount of the over-allotment option that is exercised, at a price of $1.00 per Sponsor Warrant
for an aggregate purchase price of up to $[          ] (if the over-allotment option in connection with the Public Offering is exercised in full)
(the “Over-allotment Purchase Price”), which shall be paid by wire transfer of immediately available funds to
the Company at least one day prior to the Over-allotment Closing Date in accordance with the Company’s wiring instructions. On the
Over-allotment Closing Date, following the payment by the Purchaser of the Over-allotment Purchase Price by wire transfer of immediately
available funds to the Company, the Company shall, at its option, deliver a certificate to the Purchaser evidencing the Private Placement
Warrants purchased on such date duly registered in the Purchaser’s name or effect such delivery in book-entry form.

 

(c) Terms of the Private Placement Warrants.

 

     

     

    

 

(a) The Private Placement Warrants shall have
their terms set forth in a Warrant Agreement to be entered into by the Company and a warrant agent, in connection with the Public Offering
(a “Warrant Agreement”).

 

(b) At or prior to the
time of the Initial Closing Date, the Company and the Purchaser shall enter into a registration rights agreement (the “Registration
Rights Agreement”) pursuant to which the Company will grant certain registration rights to the Purchaser relating to the
Private Placement Warrants and the Shares underlying the Private Placement Warrants.

 

Section 2. Representations and Warranties of the Company.

 

As a material inducement to the Purchaser to enter
into this Agreement and purchase the Private Placement Warrants, the Company hereby represents and warrants to the Purchaser (which representations
and warranties shall survive each Closing Date) that:

 

(a) Organization and Corporate Power. The Company
is an exempted company duly incorporated, validly existing and in good standing under the laws of the Cayman Islands and is qualified
to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect
on the financial condition, operating results or assets of the Company. The Company possesses all requisite corporate power and authority
necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement.

 

(b) Authorization; No Breach.

 

(i) The execution, delivery and performance of
this Agreement and the Private Placement Warrants have been duly authorized by the Company as of the Closing Date. This Agreement constitutes
the valid and binding obligation of the Company, enforceable in accordance with its terms. Upon issuance in accordance with, and payment
pursuant to, the terms of this Agreement, the Warrant Agreement, and the Private Placement Warrants contained therein will constitute
valid and binding obligations of the Company, enforceable in accordance with their terms as of each Closing Date, and the Ordinary Shares
issuable upon exercise of the Private Placement Warrants will be duly issued.

 

(ii) The execution and delivery by the Company
of this Agreement and the Private Placement Warrants, the issuance and sale of the Private Placement Warrants , the issuance of the Ordinary
Shares upon exercise of the Private Placement Warrants and the fulfillment, of and compliance with, the respective terms hereof and thereof
by the Company, do not and will not as of each Closing Date (A) conflict with or result in a breach of the terms, conditions or provisions
of, (B) constitute a default under, (C) result in the creation of any lien, security interest, charge or encumbrance upon the Company’s
share capital or assets under, (D) result in a violation of, or (E) require any authorization, consent, approval, exemption or other action
by or notice or declaration to, or filing with, any court or administrative or governmental body or agency pursuant to, the amended and
restated memorandum and articles of association of the Company (in effect on the date hereof or as may be amended prior to completion
of the contemplated Public Offering), or any material law, statute, rule or regulation to which the Company is subject, or any agreement,
order, judgment or decree to which the Company is subject, except for any filings required after the date hereof under federal or state
securities laws.

 

(c) Title to Securities.

 

Upon issuance in accordance with, and payment
pursuant to, and registration in the register of members of the Company, the terms hereof and the Warrant Agreement, the Private Placement
Warrants and the Ordinary Shares issuable upon exercise of the Private Placement Warrants will be duly and validly issued, fully paid
and non-assessable. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Purchaser
will have good title to the Private Placement Warrants, and the Ordinary Shares issuable upon exercise of such Private Placement Warrants,
free and clear of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions hereunder and under the other agreements
contemplated hereby, (ii) transfer restrictions under federal and state securities laws, and (iii) liens, claims or encumbrances imposed
due to the actions of the Purchaser.

 

     

     

    

 

(d) Governmental Consents.

 

No permit, consent, approval or authorization
of, or declaration to or filing with, any governmental authority is required in connection with the execution, delivery and performance
by the Company of this Agreement or the consummation by the Company of any other transactions contemplated hereby.

 

Section 3. Representations and Warranties of the Purchaser.

 

As a material inducement to the Company to enter
into this Agreement and issue and sell the Private Placement Warrants to the Purchaser, the Purchaser hereby represents and warrants to
the Company (which representations and warranties shall survive each Closing Date) that:

 

(a) Organization and Requisite Authority.

 

The Purchaser possesses all requisite power and
authority necessary to carry out the transactions contemplated by this Agreement.

  

(b) Authorization; No Breach.

 

(i) This Agreement constitutes a valid and binding
obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent conveyance, reorganization,
moratorium and other laws of general applicability relating to or affecting creditors’ rights and to general equitable principles
(whether considered in a proceeding in equity or law).

 

(ii) The execution and delivery by the Purchaser
of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser does not and shall not as of each Closing
Date conflict with or result in a breach by the Purchaser of the terms, conditions or provisions of any agreement, instrument, order,
judgment or decree to which the Purchaser is subject.

 

(c) Investment Representations.

 

(i) The Purchaser is acquiring the Private Placement
Warrants, and, upon exercise of the Private Placement Warrants, the Ordinary Shares issuable upon such exercise (collectively, the “Securities”),
for the Purchaser’s own account, for investment purposes only and not with a view towards, or for resale in connection with, any
public sale or distribution thereof.

 

(ii) The Purchaser is an “accredited investor”
as such term is defined in Rule 501(a)(3) of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”).

 

(iii) The Purchaser understands that the Securities
are being offered and will be sold to it in reliance on specific exemptions from the registration requirements of the United States federal
and state securities laws and that the Company is relying upon the truth and accuracy of, and the Purchaser’s compliance with, the
representations and warranties of the Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility
of the Purchaser to acquire such Securities.

 

(iv) The Purchaser decided to enter into this
Agreement not as a result of any general solicitation or general advertising within the meaning of Rule 502(c) under the Securities Act.

 

(v) The Purchaser has been furnished with all
materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities
which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to ask questions of the executive officers
and directors of the Company. The Purchaser understands that its investment in the Securities involves a high degree of risk and it has
sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to the
acquisition of the Securities.

 

     

     

    

 

(vi) The Purchaser understands that no
United States federal or state agency or any other government or governmental agency has passed on or made any recommendation or
endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser nor have such
authorities passed upon or endorsed the merits of the offering of the Securities.

 

(vii) The Purchaser understands that: (a) the
Securities have not been and are not being registered under the Securities Act or any state securities laws, and may not be offered for
sale, sold, assigned or transferred unless (1) in a registered transaction or (2) sold in reliance on an exemption therefrom; and
(b) except as specifically set forth in the Registration Rights Agreement, neither the Company nor any other person is under any obligation
to register the resale of the Securities under the Securities Act or any state securities laws or to comply with the terms and conditions
of any exemption thereunder. In this regard, the Purchaser understands that the Securities and Exchange Commission (the “SEC”)
has taken the position that promoters or affiliates of a blank check company and their transferees, both before and after a “business
combination”, are deemed to be “underwriters” under the Securities Act when reselling the securities of a blank check
company. Based on that position, Rule 144 adopted pursuant to the Securities Act would not be available for resale transactions of the
Securities despite technical compliance with the requirements of such Rule, and the Securities can be resold only through a registered
offering or in reliance upon another exemption from the registration requirements of the Securities Act.

 

(viii) The Purchaser has such knowledge and experience
in financial and business matters, knows of the high degree of risk associated with investments in the securities of companies in the
development stage such as the Company, is capable of evaluating the merits and risks of an investment in the Securities and is able to
bear the economic risk of an investment in the Securities in the amount contemplated hereunder for an indefinite period of time. The Purchaser
has adequate means of providing for its current financial needs and contingencies and will have no current or anticipated future needs
for liquidity which would be jeopardized by the investment in the Securities. The Purchaser can afford a complete loss of its investments
in the Securities.

 

Section 4. Conditions of the Purchaser’s Obligations.

 

The obligations of the Purchaser to purchase and
pay for the Private Placement Warrants are subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

 

(a) Representations and Warranties. The representations
and warranties of the Company contained in ‎Section 2 shall be true and correct at and as of such Closing Date as though then made.

 

(b) Performance. The Company shall have performed
and complied with all agreements, obligations and conditions contained in this Agreement that are required to be performed or complied
with by it on or before such Closing Date.

 

(c) No Injunction. No litigation, statute, rule,
regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any court
or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated
hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or the Warrant Agreement.

 

(d) Warrant Agreement. The Company shall have
entered into a Warrant Agreement with a warrant agent on terms satisfactory to the Purchaser.

 

Section 5. Conditions of the Company’s Obligations.
The obligations of the Company to the Purchaser under this Agreement are subject to the fulfillment, on or before each Closing Date, of
each of the following conditions:

 

(a) Representations and Warranties. The representations
and warranties of the Purchaser contained in ‎Section 3 shall be true and correct at and as of such Closing Date as though then
made.

 

(b) Performance. The Purchaser shall have performed
and complied with all agreements, obligations and conditions contained in this Agreement that are required to be performed or complied
with by the Purchaser on or before such Closing Date.

 

     

     

    

 

(c) No Injunction. No litigation, statute,
rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in
any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters
contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or the Warrant
Agreement.

 

(d) Warrant Agreement. The Company shall have
entered into a Warrant Agreement with a warrant agent on terms satisfactory to the Company.

 

Section 6. Termination. This Agreement may be
terminated at any time after [●], 2022 upon the election by either the Company or the Purchaser upon written notice
to the other party if the closing of the Public Offering does not occur prior to such date.

 

Section 7. Survival of Representations and Warranties.
All of the representations and warranties contained herein shall survive each Closing Date.

 

Section 8. Definitions. Terms used but not otherwise
defined in this Agreement shall have the meaning assigned to such terms in the Registration Statement on Form S-1 the Company has filed
with the SEC, under the Securities Act.

 

Section 9. Miscellaneous.

 

(a) Successors and Assigns. Except as otherwise
expressly provided herein, all covenants and agreements contained in this Agreement by or on behalf of any of the parties hereto shall
bind and inure to the benefit of the respective successors of the parties hereto whether so expressed or not. Notwithstanding the foregoing
or anything to the contrary herein, the parties may not assign this Agreement, other than assignments by the Purchaser to affiliates thereof.

 

(b) Severability. Whenever possible, each provision
of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this
Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such
prohibition or invalidity, without invalidating the remainder of this Agreement.

 

(c) Counterparts. This Agreement may be executed
simultaneously in two or more counterparts, none of which need contain the signatures of more than one party, but all such counterparts
taken together shall constitute one and the same agreement.

 

(d) Descriptive Headings; Interpretation.
The descriptive headings of this Agreement are inserted for convenience only and do not constitute a substantive part of this Agreement.
The use of the word “including” in this Agreement shall be by way of example rather than by limitation.

 

(e) Governing Law. This Agreement shall be deemed
to be a contract made under the laws of the State of New York and for all purposes shall be construed in accordance with the internal
laws of the State of New York.

 

(f) Amendments. This Agreement may not be amended,
modified or waived as to any particular provision, except by a written instrument executed by all parties hereto.

  

[Signature Page Follows]

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Agreement to be effective as of the date first set forth above.

 

	COMPANY:     	 
	 	 
	TRANSLATION DEVELOPMENT ACQUISITION CORP.	 
	 	 
	By:	 	 
	 	Name: Michael B. Hoffman	 
	 	Title: Chief Executive Officer	 
	 	 	 
	PURCHASER:  	 
	 	 	 
	STONE CAPITAL PARTNERS LLC  	 
	 	 
	By:	 	 
	 	Name: Michael B. Hoffman	 
	 	Title: Managing Member	 

 

[Signature Page – Private Warrants Purchase
Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]